Incyte
INCY
#1202
Rank
โ‚ฌ16.72 B
Marketcap
83,72ย โ‚ฌ
Share price
-0.26%
Change (1 day)
48.20%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2026 (TTM): โ‚ฌ1.51 Billion

According to Incyte's latest financial reports the company's current earnings are โ‚ฌ5.36 Billion. In 2025 the company made an earning of โ‚ฌ1.43 Billion, an increase over its 2024 earnings that were of โ‚ฌ0.27 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ1.51 B5.5%
2025 โ‚ฌ1.43 B425.68%
2024 โ‚ฌ0.27 B-62.04%
2023 โ‚ฌ0.71 B57.66%
2022 โ‚ฌ0.45 B-7.24%
2021 โ‚ฌ0.49 B-345.65%
2020 -โ‚ฌ0.21 Billion-147.7%
2019 โ‚ฌ0.41 B322.02%
2018 โ‚ฌ99.39 M-136.94%
2017 -โ‚ฌ0.27 Billion-390.76%
2016 โ‚ฌ92.55 M1322%
2015 โ‚ฌ6.5 M-115.56%
2014 -โ‚ฌ41.84 Million-41.4%
2013 -โ‚ฌ71.4 Million87.67%
2012 -โ‚ฌ38.05 Million-74.9%
2011 -โ‚ฌ0.16 Billion843.59%
2010 -โ‚ฌ16.06 Million-88.68%
2009 -โ‚ฌ0.15 Billion1.37%
2008 -โ‚ฌ0.14 Billion86.16%
2007 -โ‚ฌ75.19 Million17.64%
2006 -โ‚ฌ63.91 Million-28.62%
2005 -โ‚ฌ89.54 Million-36.1%
2004 -โ‚ฌ0.15 Billion-2.03%
2003 -โ‚ฌ0.15 Billion22.26%
2002 -โ‚ฌ0.12 Billion-27.39%
2001 -โ‚ฌ0.17 Billion198.72%
2000 -โ‚ฌ53.94 Million132.2%
1999 -โ‚ฌ23.23 Million-556.86%
1998 โ‚ฌ5.08 M-37.23%
1997 โ‚ฌ8.09 M-259.32%
1996 -โ‚ฌ5.09 Million-45.87%
1995 -โ‚ฌ9.4 Million-9.17%
1994 -โ‚ฌ10.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚ฌ13.60 B 789.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ9.12 B 497.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ26.82 B 1,654.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.83 B 412.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.14 B-90.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚ฌ43.82 Million-102.87%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚ฌ59.67 Million-103.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚ฌ25.03 Million-101.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚ฌ49.93 Million-103.27%๐Ÿ‡บ๐Ÿ‡ธ USA